niraparib
New Standard of Care for Metastatic Castration-Sensitive Prostate Cancer?
Adding niraparib (Zejula, GSK) to abiraterone acetate (Akeega, Janssen) plus prednisone (AAP) can help improve ...
JULY 23, 2025
Akeega Plus Prednisone Approved for BRCA-mutated mCRPC
The FDA approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), ...
AUGUST 14, 2023
FDA Grants New Indication for Zejula
The FDA approved a new indication for niraparib, an oral, once-daily poly PARP inhibitor, as a monotherapy ...
MAY 8, 2020
Zejula Monotherapy Approved for Some Late-Line Gyn Cancers
The FDA granted approval for an expanded indication for the poly(adenosine diphosphate–ribose) polymerase ...
OCTOBER 28, 2019
Zejula and Complementary Dx OK’d for Maintenance in Ovarian, Fallopian Tube or Primary Peritoneal Ca
The drug was approved for the maintenance treatment of patients with recurrent epithelial ovarian, fallopian ...
MARCH 29, 2017
Niraparib Extends PFS After Chemo in Ovarian Cancer
Copenhagen, Denmark—Substantial gains in progression-free survival (PFS) can be achieved when patients with ...
DECEMBER 29, 2016
